Quadcap Wealth Management’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
Other funds holding OVID
Quadcap Wealth Management's OVID Position: Q3 2026 in Review
Quadcap Wealth Management held its Ovid Therapeutics (OVID) position steady in Q3 2026 at 11,111 shares worth $27.7K. The position accounts for ﹤0.01% of the portfolio, ranked #425.
Quadcap Wealth Management first reported a position in OVID in Q3 2025 and has held it in 5 quarters since. The position peaked at $29.9K in Q2 2026. 127 funds tracked by Wall St. Rank hold OVID as of Q3 2026.
- Quadcap Wealth Management held 11,111 shares of Ovid Therapeutics worth $27.7K as of Q3 2026.
- Quadcap Wealth Management left its Ovid Therapeutics share count unchanged in Q3 2026.
- Ovid Therapeutics made up ﹤0.01% of Quadcap Wealth Management's portfolio in Q3 2026, its #425 holding.
- Quadcap Wealth Management first reported a position in Ovid Therapeutics in Q3 2025 and has held it in 5 quarters since.
- Quadcap Wealth Management's Ovid Therapeutics position peaked at $29.9K in Q2 2026.
- 127 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.
Based on Quadcap Wealth Management's 13F filing for Q3 2026, filed 2 Nov 2026.